$VEEV

Schwenger Thomas D. sold $2.8M of VEEV

Schwenger Thomas D. (Pres. & Chief Customer Officer) sold 10,000 shares of VEEVA SYSTEMS INC (VEEV) at $281.33 ($2.81M total) on 2026-08-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schwenger Thomas D.
Published Aug 31, 2026, 8:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 31, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VEEV
Bearish
medium confidence
Mentioned
$VEEV
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VEEVBearishLow
01

Why it matters

The disclosed sale provides fresh data for traders assessing short‑term price direction.

02

Market read

First‑report insider transaction; modest relevance for short‑term traders.

03

What to watch

The insider's remaining stake still represents a significant ownership percentage.

Relevance 5/10Novelty 5/10Timing: post‑market 2026‑08‑27

Background

Veeva Systems filed a Form 4 reporting an insider sale under a 10b5‑1 plan.

Company-level read

Ticker impact

$VEEVBearishMedium confidence
Context

Form 4 shows President & Chief Customer Officer sold 10,000 shares for $2.8M, reducing his stake to 19,449 shares.

Expected impact

Possible modest decline over the next few days as market digests the sale.

Evidence & confidence

The insider holds a senior role and sold a sizable block; such sales often lead to short-term sell pressure.

Market effects

Minimal impact on the broader health‑care software sector.

U.S. market only; no regional ripple.

Low global relevance.

Counterpoint

The sale could be a routine portfolio rebalancing, not a bearish signal.

Key entities

  • Thomas D. Schwenger

    President & Chief Customer Officer of Veeva Systems.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VEEVHighAI 8/10

Veeva (VEEV) Q2 2027 Earnings Call Transcript

Veeva Systems (VEEV) reported Q2 2027 revenues of $928.0 million, up 18% YoY, driven by growth in commercial and R&D segments. Subscription revenues rose 16% to $766.8 million. Non-GAAP operating income was $415.9 million, with a 44.8% margin. The company raised FY 2027 revenue guidance to $3.682B-$3.687B and EPS guidance to $9.21. Management highlighted strong adoption of Vault CRM and Data Cloud solutions, with 12 top 20 biopharmas committed to Vault CRM. Risks include the launch of the new Fa

$VEEVHighAI 9/10

VEEV Looks 5.0% Undervalued on GF Value™

Veeva Systems (VEEV) shares rose 9% after-hours on August 30, 2026, following stronger-than-expected Q2 results and raised full-year guidance. GF Value™ estimates VEEV as 5.0% undervalued at $276.69, with a GF Score™ of 95. Subscription revenues grew 16% to $766.8M. Insiders sold $18.1M in shares, while 8 gurus hold the stock, with 7 adding positions.

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$VEEVHighAI 9/10

Why Veeva Systems Stock Is Soaring This Week

Veeva Systems (VEEV) stock rose 13.8% after its Q2 fiscal 2027 earnings beat estimates, with adjusted EPS of $2.35 on revenue of $928M, up 18% YoY. The company also raised its full-year guidance above analyst expectations.